Pharmaceuticals

Welcome to the 'Pharmaceuticals' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Pharmaceuticals'.

Latest blogosphere posts tagged “Pharmaceuticals”

• The Case for Specialty Medicines: Is Industry Credible, or Culpable?

  
  PharmExec Blog — Authority: 484
  What’s so special about specialty? This was the question lurking below the surface in many of the presentations at a conference hosted by Pharm Exec’s sister organization, CBI, in Philadelphia last week. Now that the blockbuster era is fading under a wave of patent expirations, big pharma is pinning its hopes on ...
  8 hours ago

• (ASH) Investing in the Biotech Sector: Here’s An Easy Way to Profit from Biotech Stocks

  
  Stock Blog Hub — Authority: 506
  by Marc Lichtenfeld , Healthcare Expert Wednesday, November 11, 2009: Issue #1135 Investing in the biotech sector can be risky – no doubt about that. But you know what? There are a lot of ways to make money from biotech stocks, too. If you know what to look for, that is. Two obvious examples include: ...
  8 hours ago

• (SNTS) Top Performer for Wed: Santarus- Zacks #1 Rank Top Performers

  
  Stock Blog Hub — Authority: 506
  Shares of Santarus, Inc. ( SNTS ) have moved north of 7.5% this morning, which has made this specialty biopharmaceutical company a top-performing Zacks #1 Rank stock. Last week, the company announced third-quarter results that included another positive earnings per share surprise, as well as a raised 2009 guidance. ...
  9 hours ago

• (ENZN) Enzon Beats Expectations – Announces Sell-off

  
  Stock Blog Hub — Authority: 506
  Enzon ( ENZN ) achieved break-even earnings during the third quarter of 2009, better than the Zacks Consensus Estimate of loss of 7 cents but below the year-ago earnings of 1 cent. The company reported revenues of $44.6 million, a decline of 9% compared to $48.8 million reported in the third quarter of 2008. Enzon ...
  9 hours ago

• (OPTR) Optimer Pharma Beats Estimates

  
  Stock Blog Hub — Authority: 506
  Optimer Pharma’s ( OPTR ) third quarter loss per share came in at 28 cents, better than the Zacks Consensus Estimate of a loss of 36 cents and loss of 31 cents reported in the year-ago period. The company does not have any marketed products at present; it derives revenues primarily in the form of research grants ...
  9 hours ago

• Book Review: All Medicines Are Poison!

  
  Better Health — Authority: 600
  That’s the title of a new book by Melvin H. Kirschner, M.D. When I first saw the title, I expected a polemic against conventional medicine. The first line of the Preface reassured me: “Everything we do has a risk-benefit ratio.” Dr. Kirschner took the title from his first pharmacology lecture in medical ...
  10 hours ago

• Hospira Propofol, Liposyn Recalled Over Particulate Matter

  
  NewsInferno — Authority: 531
  Hospira, Inc., a global specialty pharmaceutical and medication delivery company, is voluntarily recalling 85 lots of Liposyn™ II 10%, Liposyn II 20%, Liposyn III 10%, Liposyn III 20%, Liposyn III 30%, as well as 73 lots of Propofol Injectable Emulsion 1% products that begin with lot numbers 79 and 80. The recall ...
  14 hours ago

• Spectrum Signs Deal With Nippon to Develop the Cancer Drug

  
  DataGrant Venture Capital News — Authority: 129
  On Tuesday, Irvine-based drug maker, Spectrum Pharmaceuticals Inc., has announced a deal with Nippon Kayaku Co. The deal with the Japanese company includes the production and commercialization of a cancer drug. The drug named apaziquone would be used for curing patients affected with bladder cancer that is limited up ...
  17 hours ago

• Pulmatrix Pulls in $30.2M, GenArts Gobbles Up Wondertouch, BioVex Bags $30M, & More Boston-Area Deals News

  
  Xconomy — Authority: 712
  Roundup , deals , VC Rebecca Zacks wrote: Several of New England’s tech and life sciences firms got juicy deals the past week and a half. —Boston’s RunMyErrand, an online clearinghouse where busy people can find helpers for odd jobs, raised $1 million in a Series A venture financing round. The ...
  19 hours ago

• Senior Director of Biotechnology at Catalent To Present Course on Bioassays

  
  EPR Network Blog — Authority: 146
  Released on: November 11, 2009, 12:57 amAuthor: Jennings and Co.Industry: PharmaceuticalsAna T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, will be leading a course in Bioassay Method Development and Validation. The course is being offered through IBC Life Science on November ...
  20 hours ago

• Sanofi Taps Biotech Firm to Bolster Its Pipeline

  
  NYT > Theater — Authority: 913
  The drugs being developed are monoclonal antibodies, which are engineered versions of proteins naturally made by the immune system.
  23 hours ago

• Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston-Area Biotechs

  
  Xconomy — Authority: 712
  Life Sciences , Drug Development , biotechnology Ryan McBride wrote: Sanofi-Aventis (NYSE: SNY ) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why Boston-area biotech companies should want to form partnerships with the French drug giant. It was an ...
  1 day ago

• Reinforcing the Progressives

  
  Net News Publisher — Authority: 155
  Yesterday I used my Chutzpah of the Week award to call attention to the nine Democrats in the House of Representatives who voted against health care reform in betrayal of their representation of a sizable portion of their electorate currently without any form of health insurance. Having done this, I should ...
  1 day ago

• Vertex Turns $109M Debt Into Stock

  
  Xconomy — Authority: 712
  Biotech , Hepatitis C , Finances Luke Timmerman wrote: Vertex Pharmaceuticals, the Cambridge, MA-based developer of treatments for hepatitis C, said today that investors who hold about $109 million worth of debt securities have converted those holdings into equity stakes. The deal doesn’t leave Vertex ...
  1 day ago

• Making Sense of Diabetes Video Contest - Video

  
  Religion — Authority: 845
  Budding Videographers Vividly Portray Life with Diabetes to Mark World Diabetes Day
  1 day ago

• US medical firm takes trip to UK courts to sue consultant

  
  The Guardian - guardian.co.uk — Authority: 982
  The justice secretary, Jack Straw, has invited Peter Wilmshurst, a leading British doctor, to the Ministry of Justice tomorrow to describe his experience as a victim of what he believes is libel tourism. Wilmshurst is a consultant cardiologist at Shrewsbury hospital with strong views about the need to protect ...
  1 day ago

• Generic Drug Makers

  
  Phils Stock World — Authority: 536
  Here’s another terrific post by Pharmboy, this time discussing Generic Drug Makers. - Ilene Generic Drug Makers Courtesy of Pharmboy Coming to the end of a good year, and good riddance for some!  Whilst the market has been irrational for some time, it is not about what we think but rather about what ...
  1 day ago

• L’Oréal Paris Women of Worth – www.womenofworth.com - Video

  
  Religion — Authority: 845
  LOréal Paris Fourth Annual Women of Worth Program Honors 10 Extraordinary Women Dedicated to Volunteerism and Community
  1 day ago

• Three New England Deal Stories: Startups Pursuing Emotional Sensors, Drugs for Pets, & Mobile Video Raise Some Bucks

  
  Xconomy — Authority: 712
  VC , deals , startups Ryan McBride wrote: We spotted three New England startups today that have recently filed papers with the SEC to report new rounds of equity financing. Other than their common geographic ties to region, it’s tough to see any relationship among these firms. But here’s a brief ...
  1 day ago

• Long-Lasting Beauty Tips - Video

  
  Religion — Authority: 845
  Elite Reader Panel Agrees New Products Keep Breath Feeling Fresh Longer
  1 day ago

Comments about Pharmaceuticals